News/ News/ R&D Steve Paul reignites xanomeline research as Karuna CEO Richard Staines Biotech, Eli Lilly, Karuna, mental health, schizophrenia 0 Comment Karuna aims to overcome safety concerns with combination therapy Share X Steve Paul reignites xanomeline research as Karuna CEO https://pharmaphorum.com/news/steve-paul-reignites-xanomeline-research/
News/ News/ R&D Wellcome Trust awards $8m cash injection to trial schizophrenia drug Joy Persaud Karuna, PureTech, schizophrenia, Wellcome Trust 0 Comment The Wellcome Trust has awarded $8 million to PureTech’s Karuna to take its schizophrenia drug into mid-stage trials. Share X Wellcome Trust awards $8m cash injection to trial schizophrenia drug https://pharmaphorum.com/news/wellcome-trust-awards-trial-schizophrenia-drug/